Regardless of birthplace, women who are Asian Pacific Islanders appear to have a higher risk of developing ovarian clear cell cancer compared with other ethnicities.
CMS recently announced that patients with germline ovarian or breast cancer would be covered for diagnostic testing that uses next-generation sequencing.
A pervading theme of this guideline was the importance of including genetic counselors in the interpretation and communication of germline and somatic testing results.
Review highlights limitations of trial design; additional research needed to address uncertainties.
The decision to adopt bevacizumab could be appraised by the prior level of uptake among their peers in their medical community.
In this first reported prospective study, researchers compared outcomes of fertility-sparing surgery with radical surgery in women with stage I nonepithelial ovarian cancer.
Germline PALB2 pathogenic variants were associated with an increased risk of female or male breast cancer, as well as ovarian and pancreatic cancer.
Benefit substantial for homologous-recombination deficiency positive tumors with, without BRCA mutations
Genetic testing provided important information beyond personal and family history.
Addition of surgery prior to chemotherapy does not prolong overall survival in recurrent ovarian cancer.
Rates for breast, cervical, colorectal cancer screening lower compared with women without diabetes.
There is interest in determining whether antiangiogenic therapies can act synergistically with checkpoint blockade in the setting of recurrent ovarian cancer.
The benefit was seen in an all-comers population, according to the presenters at ESMO Congress 2019.
Results of a prospective study comparing effectiveness of ultrasound screening and salpingo-oophorectomy in preventing ovarian cancer are presented.
Novel noncontraceptive benefit seen for all intrauterine devices.
Researchers sought to analyze how pain management affects quality of life and overall survival for patients with recurrent ovarian cancer.
Risk up with diagnosis of stress-related disorders or an occurrence of stressful life events around diagnosis.
Survivors of NHL should be offered genetic counseling.
Black women with cervical cancer were less likely to receive brachytherapy and had poorer survival, suggesting brachytherapy may mediate survival outcomes.
The sNDA is supported by data from the multicenter phase 2 QUADRA trial that evaluated the safety and activity of Zejula in 463 patients.